Disparities in gynecologic cancer genetics evaluation

Emily M. Hinchcliff, Erica M. Bednar, Karen H. Lu, J. Alejandro Rauh-Hain

Research output: Contribution to journalReview articlepeer-review

48 Scopus citations

Abstract

An estimated 2–5% of endometrial cancers and 15–20% of high-grade, non-mucinous epithelial ovarian cancers have an underlying hereditary cause. Appropriate risk assessment, genetic counseling, and germline genetic testing for cancer predisposition genes in both gynecologic cancer patients and their at-risk relatives is essential for effective delivery of tailored cancer treatment and cancer prevention. However, significant disparities exist within medically underserved and minority populations in the United States regarding awareness of, access to, and use of genetic services. The objectives of this review are to summarize the literature on genetic counseling and genetic testing of gynecologic cancer patients, the cascade genetic testing of their families following the identification of a germline mutation associated with susceptibility to cancer, to highlight disparities between populations, and to present some potential remedies.

Original languageEnglish (US)
Pages (from-to)184-191
Number of pages8
JournalGynecologic oncology
Volume153
Issue number1
DOIs
StatePublished - Apr 2019

Keywords

  • BRCA
  • Disparities
  • Genetic
  • Genetic evaluation
  • Lynch syndrome

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Disparities in gynecologic cancer genetics evaluation'. Together they form a unique fingerprint.

Cite this